Maryline Iva
About Maryline Iva
Maryline Iva is the Worldwide Commercialization, Multiple Myeloma Lead at Bristol Myers Squibb, with extensive experience in managing commercial product strategies for Hematology in ex-US markets.
Company
Maryline Iva is currently employed at Bristol Myers Squibb. In her role, she serves as the Worldwide Commercialization Lead for Multiple Myeloma, operating out of Suisse. Bristol Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines to help patients prevail over serious diseases.
Title
Maryline Iva holds the position of Worldwide Commercialization Lead for Multiple Myeloma at Bristol Myers Squibb. Her role involves overseeing global commercial strategies for Multiple Myeloma products, ensuring alignment with brand strategies, and maximizing revenue opportunities.
Previous Positions
Prior to her current role, Maryline Iva held various positions in the biopharmaceutical and marketing sectors. She was Associate Director, Worldwide Brand and Franchise Communications (Hematology) at Celgene from 2016 to 2020 in Switzerland. From 2015 to 2016, she was Communications and Patient Advocacy Manager (Immunology & Inflammation) at Celgene in Paris, France. At Stallergenes Greer, she served as Global Communications Director from 2010 to 2014 and Communications Manager from 2001 to 2005 in Antony, Île-de-France, France. Earlier in her career, she worked as an Account Manager at Signature s.r.o. (Rép. tchèque) from 2006 to 2009 in Prague, Czech Republic.
Education and Expertise
Maryline Iva has a comprehensive educational background with a focus on management and communication. She studied General Management at IMD Business School, achieving Foundations for Business Leadership in 2019. She holds a DESS in Communication des Entreprises from Université de Marne-la-Vallée (2000-2001) and a DESS in Marketing & Communication from CELSA Paris-Sorbonne (1997-2001). Additionally, she has studied Pharma Market Access in Europe at C.E.L.forpharma.
Commercialization and Strategy
Maryline Iva has extensive experience managing commercial product strategies, especially for Hematology (Multiple Myeloma) in ex-US markets. As a core member of the global brand team representing EU markets, she drives strategy implementation for in-line products. Her responsibilities include ensuring alignment of brand strategies, overseeing planning, analytics, and execution to maximize revenue opportunities and achieve commercial targets. She also emphasizes the importance of operational excellence and a culture of best practices.